Artiva Biotherapeutics, Inc.(ARTV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ARTV Artiva Biotherapeutics, Inc.

未开盘 11-04 16:00:00 EST

11.19

+0.47

+4.38%

盘后11.19

+0.000.00%

16:02 EST

最高11.30	最低10.50	成交量2.57万
今开10.77	昨收10.72	日振幅7.46%
总市值2.72亿	流通市值4,501万	总股本2,429万
成交额28.40万	换手率0.64%	流通股本402.23万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ARTV","market":"US","secType":"STK","nameCN":"Artiva Biotherapeutics, Inc.","latestPrice":11.19,"timestamp":1730754000000,"preClose":10.72,"halted":0,"volume":25740,"hourTrading":{"tag":"盘后","latestPrice":11.19,"preClose":11.19,"latestTime":"16:02 EST","volume":640,"amount":7161.6,"timestamp":1730754145329},"delay":0,"floatShares":4022264,"shares":24287144,"eps":-40.188656,"marketStatus":"未开盘","marketStatusCode":0,"change":0.47,"latestTime":"11-04 16:00:00 EST","open":10.77,"high":11.3,"low":10.5,"amount":284012.04546,"amplitude":0.074627,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-40.188656,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1730797200000},"adr":0,"listingDate":1721361600000,"adjPreClose":10.72,"postHourTrading":{"tag":"盘后","latestPrice":11.19,"preClose":11.19,"latestTime":"16:02 EST","volume":640,"amount":7161.6,"timestamp":1730754145329},"volumeRatio":0.535035},"requestUrl":"/m/hq/s/ARTV","defaultTab":"news","newsList":[{"id":"2481553946","title":"Artiva Biotherapeutics, Inc.盘中异动 股价大涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481553946","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481553946?lang=zh_cn&edition=full","pubTime":"2024-11-05 03:21","pubTimestamp":1730748076,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日03时21分，Artiva Biotherapeutics, Inc.股票出现异动，股价快速拉升5.41%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大，Elevai Labs, Inc.、Nls Pharmaceutics Ltd.、Gri Bio, Inc.较为活跃，换手率分别为450.53%、284.37%、100.31%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、Ocean Biomedical Inc C/Wts 14/02/2028 、In8Bio, Inc.，振幅分别为52.25%、45.56%、45.39%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105032116a215c0d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105032116a215c0d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2480078854","title":"Artiva Biotherapeutics, Inc.盘中异动 临近收盘快速拉升5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480078854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480078854?lang=zh_cn&edition=full","pubTime":"2024-11-02 04:00","pubTimestamp":1730491246,"startTime":"0","endTime":"0","summary":"北京时间2024年11月02日04时00分，Artiva Biotherapeutics, Inc.股票出现异动，股价急速拉升5.42%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Revolution Medicines Inc C/Wts 17/12/2026 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Theriva Biologics, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.较为活跃，换手率分别为3740.76%、955.40%、905.74%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 、Immatics N V C/Wts 01/07/2025 ，振幅分别为122.67%、101.75%、62.87%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102040046971a3ef0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102040046971a3ef0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2479759081","title":"Artiva Biotherapeutics, Inc.盘中异动 股价大跌5.25%报10.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479759081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479759081?lang=zh_cn&edition=full","pubTime":"2024-10-31 03:20","pubTimestamp":1730316048,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日03时20分，Artiva Biotherapeutics, Inc.股票出现波动，股价大幅下跌5.25%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Tharimmune, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Ensysce Biosciences, Inc.涨幅较大，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.较为活跃，换手率分别为5214.32%、3108.16%、432.49%，振幅较大的相关个股有Tharimmune, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Ensysce Biosciences, Inc.，振幅分别为146.80%、91.64%、77.90%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031032048ab85d68b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031032048ab85d68b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2478482724","title":"Artiva Biotherapeutics, Inc.盘中异动 急速上涨5.16%报11.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478482724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478482724?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:43","pubTimestamp":1730126595,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时43分，Artiva Biotherapeutics, Inc.股票出现波动，股价快速上涨5.16%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Monte Rosa Therapeutics, Inc.、Eyepoint Pharmaceuticals, Inc.涨幅较大，Tc Biopharm  Plc、Genprex, Inc.、Viracta Therapeutics, Inc.较为活跃，换手率分别为640.02%、56.59%、53.23%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Klotho Neurosciences Inc C/Wts 21/06/2029 、Monte Rosa Therapeutics, Inc.，振幅分别为87.13%、84.14%、46.83%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028224316a1f2743b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028224316a1f2743b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2478338189","title":"Artiva Biotherapeutics, Inc.盘中异动 股价大涨5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478338189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478338189?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:31","pubTimestamp":1729863069,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时31分，Artiva Biotherapeutics, Inc.股票出现波动，股价急速拉升5.81%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Elevai Labs, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、180 Life Sciences Corp.涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为445.82%、279.08%、22.77%，振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、180 Life Sciences Corp.、Elevai Labs, Inc.，振幅分别为66.85%、20.36%、18.76%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025213109a1ea7ff6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025213109a1ea7ff6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2477563747","title":"Artiva Biotherapeutics, Inc.盘中异动 快速下挫7.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477563747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477563747?lang=zh_cn&edition=full","pubTime":"2024-10-24 03:14","pubTimestamp":1729710889,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日03时14分，Artiva Biotherapeutics, Inc.股票出现波动，股价大幅下跌7.17%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.27%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Virax Biolabs Group Limited涨幅较大，Virax Biolabs Group Limited、Cns Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1921.84%、1649.67%、520.46%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为129.93%、109.26%、95.84%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024031449971a1df7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024031449971a1df7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2477297356","title":"Artiva Biotherapeutics, Inc.盘中异动 早盘大幅拉升5.44%报11.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477297356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477297356?lang=zh_cn&edition=full","pubTime":"2024-10-22 23:00","pubTimestamp":1729609203,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日23时00分，Artiva Biotherapeutics, Inc.股票出现异动，股价急速上涨5.44%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.84%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为4440.72%、3933.23%、1949.11%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Aptevo Therapeutics Inc.、Genprex, Inc.，振幅分别为170.68%、99.41%、81.46%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022230004971a1a1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022230004971a1a1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2477647218","title":"Artiva Biotherapeutics, Inc.盘中异动 早盘股价大跌5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477647218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477647218?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:53","pubTimestamp":1729522393,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日22时53分，Artiva Biotherapeutics, Inc.股票出现异动，股价急速下跌5.96%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.73%。其相关个股中，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为5084.46%、2796.36%、1161.20%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Aptevo Therapeutics Inc.，振幅分别为292.25%、157.02%、118.79%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102122531398e3d8fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102122531398e3d8fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2476242481","title":"Artiva Biotherapeutics, Inc.盘中异动 大幅跳水5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476242481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476242481?lang=zh_cn&edition=full","pubTime":"2024-10-18 02:21","pubTimestamp":1729189265,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日02时21分，Artiva Biotherapeutics, Inc.股票出现异动，股价急速下挫5.07%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Molecular Templates, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Engene Holdings Inc C/Wts 31/10/2028  Cl A涨幅较大，Molecular Templates, Inc.、Notable Labs, Ltd.、180 Life Sciences Corp.较为活跃，换手率分别为2610.45%、937.91%、280.01%，振幅较大的相关个股有Molecular Templates, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为259.74%、147.48%、104.84%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101802210598e3d0f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101802210598e3d0f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2475891647","title":"Artiva Biotherapeutics, Inc.盘中异动 股价大跌5.09%报11.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475891647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475891647?lang=zh_cn&edition=full","pubTime":"2024-10-16 22:31","pubTimestamp":1729089079,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日22时31分，Artiva Biotherapeutics, Inc.股票出现异动，股价急速下跌5.09%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.88%。其相关个股中，180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Korro Bio, Inc.涨幅较大，180 Life Sciences Corp.、Biodexa Pharmaceuticals Plc、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为5329.30%、974.27%、360.41%，振幅较大的相关个股有180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为623.68%、279.52%、121.40%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101622311998e3ccc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101622311998e3ccc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2475396390","title":"Artiva Biotherapeutics, Inc.盘中异动 股价大跌5.17%报14.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475396390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475396390?lang=zh_cn&edition=full","pubTime":"2024-10-14 22:54","pubTimestamp":1728917689,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日22时54分，Artiva Biotherapeutics, Inc.股票出现异动，股价急速下跌5.17%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Tevogen Bio Holdings Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Aditxt, Inc.、Tevogen Bio Holdings Inc.、Rani Therapeutics Holdings, Inc.较为活跃，换手率分别为185.45%、99.53%、97.45%，振幅较大的相关个股有Tevogen Bio Holdings Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为149.47%、119.46%、69.12%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014225449ab69ff99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014225449ab69ff99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2473406482","title":"Artiva Biotherapeutics, Inc.盘中异动 快速下跌6.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473406482","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473406482?lang=zh_cn&edition=full","pubTime":"2024-10-08 02:43","pubTimestamp":1728326599,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日02时43分，Artiva Biotherapeutics, Inc.股票出现波动，股价大幅跳水6.42%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Scholar Rock Holding Corporation、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Aditxt, Inc.、Tc Biopharm  Plc、Phio Pharmaceuticals Corp.较为活跃，换手率分别为1647.92%、87.88%、60.65%，振幅较大的相关个股有Scholar Rock Holding Corporation、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Akari Therapeutics Plc，振幅分别为107.82%、39.46%、37.93%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008024319ab6822e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008024319ab6822e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2473998063","title":"Artiva Biotherapeutics, Inc.盘中异动 快速上涨5.26%报16.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473998063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473998063?lang=zh_cn&edition=full","pubTime":"2024-10-05 01:44","pubTimestamp":1728063860,"startTime":"0","endTime":"0","summary":"北京时间2024年10月05日01时44分，Artiva Biotherapeutics, Inc.股票出现波动，股价急速拉升5.26%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Aditxt, Inc.、Theriva Biologics, Inc.、Windtree Therapeutics, Inc.较为活跃，换手率分别为17127.37%、73.03%、62.31%，振幅较大的相关个股有Aditxt, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Cue Biopharma, Inc.，振幅分别为69.59%、58.64%、52.37%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100501442198e3aa58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100501442198e3aa58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"2472489571","title":"Artiva Biotherapeutics, Inc.盘中异动 大幅上涨5.12%报16.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472489571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472489571?lang=zh_cn&edition=full","pubTime":"2024-10-03 00:55","pubTimestamp":1727888143,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日00时55分，Artiva Biotherapeutics, Inc.股票出现异动，股价大幅上涨5.12%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.93%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Aditxt, Inc.、Windtree Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1108.30%、55.59%、51.27%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Apollomics Inc C/Wts 01/04/2028 、Aditxt, Inc.，振幅分别为145.55%、60.44%、51.53%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100300554398e3a3eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100300554398e3a3eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2472376653","title":"Artiva Biotherapeutics, Inc.盘中异动 早盘快速上涨6.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472376653","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472376653?lang=zh_cn&edition=full","pubTime":"2024-10-01 21:36","pubTimestamp":1727789817,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日21时36分，Artiva Biotherapeutics, Inc.股票出现波动，股价大幅上涨6.89%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Aditxt, Inc.、Silexion Therapeutics Corp、Briacell Therapeutics Corp.较为活跃，换手率分别为517.86%、452.31%、58.91%，振幅较大的相关个股有Briacell Therapeutics Corp.、Bioatla, Inc.、Briacell Therapeutics Corp C/Wts 24/02/2025，振幅分别为30.65%、26.70%、21.95%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001213657a1dddc2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001213657a1dddc2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2471386888","title":"Artiva Biotherapeutics, Inc.盘中异动 股价大涨5.21%报14.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471386888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471386888?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:34","pubTimestamp":1727703266,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时34分，Artiva Biotherapeutics, Inc.股票出现异动，股价快速拉升5.21%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Prime Medicine, Inc.涨幅较大，Aditxt, Inc.、Windtree Therapeutics, Inc.、Onconetix, Inc.较为活跃，换手率分别为37.52%、18.37%、15.55%，振幅较大的相关个股有Prime Medicine, Inc.、Seelos Therapeutics, Inc.、Vor Biopharma Inc.，振幅分别为16.76%、11.28%、9.87%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930213426ab672756&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930213426ab672756&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2470267103","title":"Artiva Biotherapeutics, Inc.盘中异动 急速上涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470267103","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470267103?lang=zh_cn&edition=full","pubTime":"2024-09-25 23:50","pubTimestamp":1727279448,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日23时50分，Artiva Biotherapeutics, Inc.股票出现波动，股价大幅拉升5.15%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Surrozen Inc C/Wts 01/08/2031 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Seelos Therapeutics, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为294.17%、203.58%、95.80%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Cero Therapeutics Holdings, Inc.、塞德斯医疗，振幅分别为107.20%、85.38%、45.14%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925235049ab65ed17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925235049ab65ed17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARTV","BK4139"],"gpt_icon":0},{"id":"2468682281","title":"Artiva Biotherapeutics, Inc.盘中异动 临近收盘股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468682281","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468682281?lang=zh_cn&edition=full","pubTime":"2024-09-20 03:45","pubTimestamp":1726775130,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日03时45分，Artiva Biotherapeutics, Inc.股票出现波动，股价快速下跌5.29%。Artiva Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.94%。其相关个股中，Exicure, Inc.、Edgewise Therapeutics, Inc.、Achilles Therapeutics Plc Ads Each Repr 1 Share Spon涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Portage Biotech Inc.较为活跃，换手率分别为5563.67%、1003.76%、231.17%，振幅较大的相关个股有Exicure, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Galmed Pharmaceuticals Ltd.，振幅分别为110.91%、88.80%、81.88%。Artiva Biotherapeutics, Inc.公司简介：Artiva Biotherapeutics Inc 是一家生物制药公司。该公司的管道项目包括Artiva-Funded Trials和Collaborator-Funded Trials。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920034530a1db3bb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920034530a1db3bb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARTV"],"gpt_icon":0},{"id":"1149072537","title":"异动解读 | Artiva Biotherapeutics IPO大涨31% 投资者看好其细胞疗法前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1149072537","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149072537?lang=zh_cn&edition=full","pubTime":"2024-07-20 01:02","pubTimestamp":1721408537,"startTime":"0","endTime":"0","summary":"临床阶段生物技术公司Artiva Biotherapeutics今日在纳斯达克挂牌上市,股价大涨31.25%,引发市场关注。Artiva Biotherapeutics专注于自身免疫性疾病和癌症细胞治疗领域,其主要候选药物AlloNK正在进行狼疫肾炎和其他自身免疫性适应症的临床试验,预计明年上半年将有初步数据公布。此外,Artiva Biotherapeutics的IPO发行价格为12美元/股,低于此前预期的14-16美元区间,发行规模也扩大至1390万股,这使得投资者认为股票具有一定的投资价值。因此,在首日交易中,Artiva Biotherapeutics股价大涨31.25%,表现强劲。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTV"],"gpt_icon":0},{"id":"2452473750","title":"生物技术公司Artiva Biotherapeutics(ARTV.US)IPO定价12美元/股 今晚登陆纳斯达克","url":"https://stock-news.laohu8.com/highlight/detail?id=2452473750","media":"智通财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452473750?lang=zh_cn&edition=full","pubTime":"2024-07-19 21:00","pubTimestamp":1721394022,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，专注于自身免疫性疾病和癌症细胞治疗的临床阶段生物技术公司Artiva Biotherapeutics宣布了IPO条款，该公司以每股12美元的价格发行了1390万股股票，筹资1.67亿美元，发行价低于此前预期的价格区间14至16美元，发行规模则比此前预期多了520万股。Artiva Biotherapeutics将于7月19日在纳斯达克开始交易，股票代码为ARTV。作为发行的一部分，Artiva还授予承销商30天的选择权，以IPO价格额外购买至多2088000万股普通股。Artiva预计将在明年上半年报告至少一项试验的初步数据。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153494.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SQQQ",".IXIC","MNQmain","QLD","ARTL","BK4007","03086","ARTV","PSQ","TQQQ","BK1147","QID","159632","NQmain"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.artivabio.com","stockEarnings":[{"period":"1week","weight":0.0557},{"period":"1month","weight":-0.2931},{"period":"3month","weight":0.009},{"period":"6month","weight":-0.0675},{"period":"ytd","weight":-0.0675}],"compareEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0055},{"period":"3month","weight":0.0913},{"period":"6month","weight":0.1017},{"period":"1year","weight":0.3108},{"period":"ytd","weight":0.1988}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Artiva Biotherapeutics, Inc.于2019年2月14日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，专注于为患有破坏性自身免疫性疾病和癌症的患者开发基于自然杀伤（NK）细胞的疗法。","exchange":"NASDAQ","name":"Artiva Biotherapeutics, Inc.","nameEN":"Artiva Biotherapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Artiva Biotherapeutics, Inc.(ARTV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Artiva Biotherapeutics, Inc.(ARTV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Artiva Biotherapeutics, Inc.,ARTV,Artiva Biotherapeutics, Inc.股票,Artiva Biotherapeutics, Inc.股票老虎,Artiva Biotherapeutics, Inc.股票老虎国际,Artiva Biotherapeutics, Inc.行情,Artiva Biotherapeutics, Inc.股票行情,Artiva Biotherapeutics, Inc.股价,Artiva Biotherapeutics, Inc.股市,Artiva Biotherapeutics, Inc.股票价格,Artiva Biotherapeutics, Inc.股票交易,Artiva Biotherapeutics, Inc.股票购买,Artiva Biotherapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Artiva Biotherapeutics, Inc.(ARTV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Artiva Biotherapeutics, Inc.(ARTV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}